Back

Percutaneous transluminal alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy and drug refractory symptoms: intermediate-term outcomes of a prospective cohort.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Non-coronary cardiac interventions Noncoronary Cardiac Intervention, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Ms Maria Plaza Martin

UNIVERSITY HOSPITAL CLINIC, Valladolid (Spain)

13 More presentations in this session

Presentation thumbnail
Percutaneous balloon mitral valvuloplasty in pregnant women with severe mitral stenosis: a review of literature and meta-analysis
Doctor F. Fioravanti (Milan, IT)
Abstract
Presentation thumbnail
Safety and efficacy of left atrial appendage occlusion guided by CT-scan and intracardiac echocardiography from the left atrium.
Doctor T. Pommier (Dijon, FR)
Abstract Slides
Presentation thumbnail
Impact of left atrial appendage morphology on procedural characteristics: A two center experience with the Amplatzer Amulet Device
Assistant Professor B. Al-Kassou (Bonn, DE)
Abstract Slides
Presentation thumbnail
Infective endocarditis following transcatheter aortic valve implantation; a single centre experience out to 10 years
Doctor P. Brennan (Belfast, GB)
Abstract Slides
Presentation thumbnail
Short- and long-term mortality in patients with diabetes mellitus after TAVR: Results of an international multicenter registry.
Professor V. Veulemans (Duesseldorf, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Non-coronary cardiac interventions

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources